Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$10.88 - $17.05 $1.94 Million - $3.04 Million
-178,136 Closed
0 $0
Q4 2020

Jan 19, 2021

SELL
$9.23 - $18.18 $217,698 - $428,793
-23,586 Reduced 11.69%
178,136 $2.78 Million
Q3 2020

Nov 16, 2020

SELL
$9.38 - $12.48 $160,885 - $214,056
-17,152 Reduced 7.84%
201,722 $1.91 Million
Q2 2020

Jul 17, 2020

SELL
$6.21 - $11.83 $153,995 - $293,360
-24,798 Reduced 10.18%
218,874 $1.96 Million
Q1 2020

Apr 16, 2020

SELL
$5.05 - $8.85 $26,699 - $46,789
-5,287 Reduced 2.12%
243,672 $1.55 Million
Q4 2019

Feb 14, 2020

SELL
$8.03 - $11.7 $208,370 - $303,603
-25,949 Reduced 9.44%
248,959 $2.08 Million
Q3 2019

Nov 14, 2019

SELL
$9.05 - $12.22 $176,837 - $238,778
-19,540 Reduced 6.64%
274,908 $2.49 Million
Q2 2019

Aug 14, 2019

SELL
$8.75 - $13.03 $1.06 Million - $1.57 Million
-120,808 Reduced 29.09%
294,448 $3.17 Million
Q1 2019

May 07, 2019

SELL
$7.72 - $12.81 $217,163 - $360,345
-28,130 Reduced 6.34%
415,256 $3.96 Million
Q4 2018

Jan 25, 2019

SELL
$9.51 - $16.6 $73,892 - $128,982
-7,770 Reduced 1.72%
443,386 $5.09 Million
Q3 2018

Oct 30, 2018

SELL
$13.05 - $19.05 $211,736 - $309,086
-16,225 Reduced 3.47%
451,156 $7.65 Million
Q2 2018

Aug 03, 2018

SELL
$13.9 - $19.8 $111,297 - $158,538
-8,007 Reduced 1.68%
467,381 $6.64 Million
Q1 2018

Apr 30, 2018

SELL
$16.7 - $26.35 $39,044 - $61,606
-2,338 Reduced 0.49%
475,388 $9.03 Million
Q4 2017

Jan 18, 2018

SELL
$11.6 - $17.35 $116,719 - $174,575
-10,062 Reduced 2.06%
477,726 $7.84 Million
Q3 2017

Oct 31, 2017

BUY
$8.4 - $15.0 $4.1 Million - $7.32 Million
487,788
487,788 $7.32 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $415M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.